Plasma exchange in the management of new onset multiple myeloma with cast nephropathy treated with bortezomib based chemotherapy

Nephrology (Carlton). 2017 Dec;22(12):1035-1036. doi: 10.1111/nep.12979.

Authors

J Sethi¹, R Ramachandran¹, P Malhotra², R Nada³, Vst Pinnamaneni¹, V Kumar¹, M Rathi¹, H S Kohli¹, K L Gupta¹

Affiliations

¹ Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 29145704
DOI: 10.1111/nep.12979

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Bortezomib*
Humans
Kidney Diseases
Multiple Myeloma*
Plasma Exchange
Plasmapheresis

Substances

Bortezomib